Select committee: Women and Equalities Committee
Recommendation 4
First Report - Menopause and the Workplace
Published 28 Jul 2022
Addressed to Government Equalities Office
Women and Equalities Committee Menopause and the workplace All items in this report Report on parliament.uk ↗ Inquiry on parliament.uk ↗
Recommendation (the committee's words)
We are extremely disappointed that despite a clear Government commitment on a single-cost, annual pre-payment certificate for HRT, almost nine months later that commitment has not been realised. Progress has been further derailed by supply issues. We welcome the Health Secretary’s announcement of an ‘HRT tsar’ to consider the challenges with supply. The Government must act urgently to ensure that lower cost HRT prescriptions are being issued and dispensed. Over the next three months the Government should communicate widely to ensure GPs and patients Menopause and the workplace 47 know about both the current NICE guidelines permitting a 12-month prescription, and the forthcoming single-cost pre-payment certificate. This should include but not be limited to: (Paragraph 35) • writing to all GPs and community pharmacists to ensure they know about the new scheme • communications (for example, posters) in GP surgeries, pharmacies and walk-in centres • through the Gov.uk website and DHSC social media accounts
From: Women and Equalities Committee, First Report - Menopause and the Workplace (HC 91), 28 July 2022
Government response
The government responded to the whole report on 24 January 2023 (deadline 28 September 2022).
Summary written by Accountability Index from the government's response. It is not the government's own words.The government welcomes the Committee's report and responds to each recommendation, accepting some in full, some in principle or in part, and not accepting others.
- On a public health campaign, the government "accepts this recommendation in principle" but says that "at this stage there is already much work underway or planned". It "will keep the impact of current initiatives under review" and "continue to consider if a public health campaign may be needed in the future".
- On HRT costs, it accepts the recommendation in part. A bespoke HRT pre-payment certificate will be introduced "from April 2023, subject to consultation", costing the equivalent of two prescription charges. It does not accept a national HRT formulary, saying one "is not required".
- On flexible working, the government "accepts this recommendation" and has committed to making it a "day one" right, which it says it can do through regulations. It will "consider guidance alongside legislative developments".
- The government does not accept the recommendations to commence section 14 of the Equality Act 2010 or to consult on a new protected characteristic of menopause, saying it is "not satisfied that the evidence given to the Committee" fully supports new legislation.